๐ย ๐๐จ๐ฎ๐ง๐ญ๐๐จ๐ฐ๐ง ๐ญ๐จ ๐ญ๐ก๐ ๐๐ฎ๐ฆ๐ฆ๐ข๐ญ! Hereโs another look at one of the workshops powering the ๐๐ฎ๐ ๐๐ข๐๐ ๐๐๐ข๐๐ง๐๐๐ฌ ๐๐ฎ๐ฆ๐ฆ๐ข๐ญ ๐๐๐๐.
Pharma companies are investing heavily in AI, but are these investments translating into measurable business value โ or simply increasing costs?
At the Zug Life Sciences Summit 2026, Nick Starritt and Irene Schindeleย from Mercerย and Oliver Wymanย will host an interactive workshop:
๐๐ซ๐ย ๐๐จ๐ฎ ๐๐๐๐ฅ๐ข๐ง๐ ๐๐ โ ๐จ๐ซ ๐๐ฎ๐ฌ๐ญ ๐๐๐๐ฅ๐ข๐ง๐ ๐๐จ๐ฌ๐ญ? ๐๐ฎ๐ซ๐ง๐ข๐ง๐ ๐๐จ๐ซ๐ค๐๐จ๐ซ๐๐ ๐๐๐จ๐ฉ๐ญ๐ข๐จ๐ง ๐ข๐ง๐ญ๐จ ๐๐๐๐ฌ๐ฎ๐ซ๐๐๐ฅ๐ ๐๐ ๐๐๐
Drawing on Mercerโs Global Talent Trends 2026 and experience from large-scale AI transformations, this session will explore how leadership, workforce readiness and organisational adoption can turn AI investment into sustainable business value.
Expect:
โ Insights into where AI adoption creates value โย and where it stalls
โ Perspectives on the leadership and workforce capabilities needed to scale AI
โ Practical approaches to improve adoption and manage organisational change
โ Insights into measuring the business impact and ROI of AI investments
๐ย Register today at https://www.zugpharmagroup.com/event-details-registration/zug-life-science-summit-2026-1 to join us for this and other expert-led sessions at the 2026 Zug Life Sciences Summit.
